(Q44253334)
Statements
1 reference
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy (English)
1 reference
J Baselga
1 reference
M D Green
1 reference
H Koelbl
1 reference
A Galid
1 reference
V Guillem
1 reference
P Gascon
1 reference
S Siena
1 reference
R I Lalisang
1 reference
H Samonigg
1 reference
M R Clemens
1 reference
V Zani
1 reference
B C Liang
1 reference
J Renwick
1 reference
M J Piccart
1 reference
International Pegfilgrastim 749 Study Group
1 reference
1 January 2003
1 reference
1 reference
14
1 reference
1
1 reference
29-35
1 reference
Identifiers
1 reference
1 reference